The US government has cancelled a multimillion-dollar contract with a Maryland-based COVID-19 vaccine manufacturer where 15 million doses of the Johnson & Johnson vaccine were found to be contaminated earlier this year due to unsanitary plant conditions.

US cancels contract with Covid vaccine maker whose plant contaminated 15 million J&J jabs

The US Food and Drug Administration (FDA) has reported that nearly 60 million doses of the Johnson & Johnson coronavirus vaccine have been disposed off due to possible contamination.

Germany demands replacement of 60 million contaminated J&J vaccine doses

US’ Food and Drug Administration (FDA) has increased the shelf life of the Johnson & Johnson coronavirus vaccine from three to four-and-a-half months. This has come as a piece of good news as millions of doses stored in clinical refrigerators around the world faced the danger of expiring and experts feared they might have to toss out the existing doses.

US: FDA extends shelf-life of J&J vaccine from 3 to 4.5 months

Johnson & Johnson is in talks with India's government to begin a clinical trial of its single-dose COVID-19 vaccine in the country, the company said on Friday. The US drugs and healthcare giant's vaccine is currently approved for use in the United States, the European Union and other nations including Thailand and South Africa.

J&J says in talks with Indian government for trial of single-dose vaccine

The United States has officially authorised Johnson & Johnson's coronavirus vaccine for emergency use, making it the third approved vaccine of the county. It is the first single-dose vaccine to be available in the US.

US approves Johnson & Johnson's COVID-19 vaccine for emergency use